
Pills & Profits: Can India's pharma sector handle Trump's planned 200% tariff dose?
India stands tall as a pharmaceutical powerhouse, supplying 20% of the world’s generic medicines and nearly 62% of global vaccines. Yet, this success now faces a storm: US President Donald Trump’s proposed tariffs of up to 200% on pharmaceutical imports. …